Key Highlights: Stocks in News, Economic & Global Updates 22nd July 2026 by GEPL Capital Ltd
Stocks in News
• MANORAMA INDUSTRIES: The company incorporates Manorama Savannah Agro Chad SARL in Chad to expand its food and cosmetics trading business.
• VEDANTA OIL&GAS: The company Receives demand notices from the DGH seeking about $35 million plus interest in liquidated damages related to four OALP blocks.
• AUROBINDO PHARMA: CuraTeQ Biologics receives ANVISA GMP approval for its Hyderabad biosimilars facility.
• SEAMEC: To acquire vessel SEAMEC ANANT from HAL Offshore for $70 million, with delivery by Aug. 31, 2026.
• DELHIVERY: The company received GST appellate order from West Bengal tax authority for FY20 confirming tax demand of Rs 6.47 crore, interest demand of Rs 7.61 crore and penalty of Rs 0.65 crore over disallowance of input tax credit;
• REDINGTON: The company signed a five-year strategic agreement with Resulticks to expand AI-led customer engagement across the Middle East, India and SESA.
• PC JEWELLER: Repays all outstanding debt to one more consortium bank; 5 of 14 bank loans have now been prepaid.
• REC: RECPDCL incorporates Dharashiv Power Transmission as a wholly owned subsidiary on July 21, 2026 to act as the project SPV for the 400 kV GIS Solapur/Paranda Switching Station.
• VINTAGE COFFEE AND BEVERAGES: NCLT Hyderabad sanctions amalgamation of wholly owned subsidiaries Vintage Coffee and Delecto Foods with Vintage Coffee and Beverages through an order dated July 21, 2026.
• M&M FINANCIAL SERVICES: Receives CARE AAA/A1+ and India Ratings AAA/A1+ ratings for bank facilities and fixed deposits.
Economic News
• Fertiliser vessels stuck at ports, raise supply fears for peak kharif sowing: Fertiliser vessels are stranded at Indian ports, hindering crop nutrient supplies. Sowing has accelerated after rainfall revival, increasing demand for timely distribution. Port congestion and supply chain issues are delaying crucial fertiliser dispatches. West Asia crisis and rerouting of vessels contribute to these significant delays. Industry executives express concerns over potential disruptions to the kharif sowing season.
Global News
• U.S. sets two-year tariff-free window before imposing 100%–200% duties on generic drugs: U.S. President Donald Trump announced that imported generic drugs will remain tariff-free for two years from August 1, 2026, after which they will face a 100% tariff for one year and a 200% tariff thereafter to encourage pharmaceutical companies to shift manufacturing to the U.S. The policy does not apply to patented or branded medicines and is aimed at reducing dependence on overseas drug supplies while supporting Trump's broader reshoring agenda. The move could significantly impact India, which supplies nearly 40–50% of generic medicines used in the U.S., while China remains the largest source of active pharmaceutical ingredients (APIs). The announcement comes ahead of a fresh round of U.S. tariff measures on multiple countries as the administration pursues a tougher trade policy.
SEBI Registration number is INH000000081.
Please refer disclaimer at https://geplcapital.com/term-disclaimerg
